Grant: Project Grant
McGill University
$910,350.00
To design a new baculovirus carrying drug eluting stent for targeted vascular therapy.
FY 2018-19
Summary
Coronary artery disease is the major cause of death in the world. Most of these patients undergo artery angioplasty and stenting to avoid open heart surgery. Bare metal and pharmacological stents have been in the market for quite some time. Though effective currently available stents are facing serious stent based long term complications such as restenosis and late stent thrombosis. To address these problems, here we propose to design a new baculovirus carrying drug eluting stent. This new stent will promote accelerated healing of injured vascular tissues to prevent stent related complications. Both in vitro and experiments on animal model will be performed to investigate novel stent design, mechanism of action, safety and their preclinical efficacy. This study will advance stent design knowledge and has potential to result in a next generation of stent for use in coronary artery disease.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
402519
Name
Prakash Satya
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Pharmaceutical Sciences
Projecttitle
To design a new baculovirus carrying drug eluting stent for targeted vascular therapy.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$910,350
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Coronary Artery Disease; Stent; Targeted Delivery; Wound Healing
Abstract
Coronary artery disease is the major cause of death in the world. Most of these patients undergo artery angioplasty and stenting to avoid open heart surgery. Bare metal and pharmacological stents have been in the market for quite some time. Though effective currently available stents are facing serious stent based long term complications such as restenosis and late stent thrombosis. To address these problems, here we propose to design a new baculovirus carrying drug eluting stent. This new stent will promote accelerated healing of injured vascular tissues to prevent stent related complications. Both in vitro and experiments on animal model will be performed to investigate novel stent design, mechanism of action, safety and their preclinical efficacy. This study will advance stent design knowledge and has potential to result in a next generation of stent for use in coronary artery disease.
Competitiondate
201903
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Prakash, Satya
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $910,350~ $0~